Crea il mio profilo
Accesso pubblico
Visualizza tutto17 articoli
2 articoli
Disponibili
Non disponibili
In base ai mandati di finanziamento
Coautori
- Simon CookSignalling Programme, The Babraham InstituteEmail verificata su babraham.ac.uk
- Matthew SaleUCSFEmail verificata su ucsf.edu
- Julie WickendenPost-doctoral Researcher, University of CambridgeEmail verificata su horizondiscovery.com
- Scott NewmanGeneDxEmail verificata su sema4.com
- Sylvie GuichardExecutive Director Translational Medicine Novo NordiskEmail verificata su astrazeneca.com
- Eileen WhiteRutgers UniversityEmail verificata su cinj.rutgers.edu
- Martin TurnerThe Babraham Institute, Cambridge, CB22 3AT, UK.Email verificata su babraham.ac.uk
- Manuel D Diaz-MunozATIP-Avenir Group Leader, Toulouse Institute for Infectious and Inflammatory DiseasesEmail verificata su inserm.fr
- Anne CorcoranBabraham InstituteEmail verificata su babraham.ac.uk
- Pamela LochheadBabraham InstituteEmail verificata su babraham.ac.uk
- Timothy PERRENConsultant Medical Oncologist, Leeds teaching Hospitals NHS TrustEmail verificata su leeds.ac.uk
- Tom DunkleyLab Head Mass Spectrometry, Roche Innovation Center Basel @ pREDEmail verificata su roche.com
- Kevin HudsonAstraZenecaEmail verificata su astrazeneca.com
- Martin McMahonCumming-Presidential Professor of Cancer Biology, Huntsman Cancer Institute, Univ. of UtahEmail verificata su hci.utah.edu
- John LunecNewcastle UniversityEmail verificata su ncl.ac.uk
- Duncan JodrellProfessor of Cancer Therapeutics, University of CambridgeEmail verificata su cam.ac.uk
- Mark CockerillCancer Research UK